Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Loncar Cancer Immunotherapy ETF (NQ: CNCR )

31.20 USD -0.82 (-2.56%)
Official Closing Price Updated: 4:00 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Loncar Cancer Immunotherapy ETF

Loncar China BioPharma ETF (CHNA) Launches on Nasdaq
Loncar China BioPharma ETF (CHNA) launches on Nasdaq. CHNA offers exposure to leading companies in China’s burgeoning BioPharma industry. 
From Business Wire News Releases
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management
Loncar Cancer Immunotherapy ETF (CNCR) surpasses $50 million in assets under management. 
From Business Wire News Releases
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance. Three Biotechnology Companies Added to the Index. 
From Business Wire News Releases
Loncar Cancer Immunotherapy Index Announces Merger Replacements
Loncar Cancer Immunotherapy Index Announces Merger Replacements. Gilead and NewLink Added to the Only Index that Tracks Cancer Immunotherapy. 
From Business Wire News Releases
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance. Three Biotechnology Companies Added to the Index. 
From Business Wire News Releases
Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell
From GlobeNewswire News Releases
Cancer Immunotherapy ETF Celebrates One-Year Anniversary
The cancer immunotherapy ETF is celebrating its one-year anniversary. Cancer immunotherapy companies are beneficially disrupting status quo cancer treatments. 
From Business Wire News Releases
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance. Two New Immunotherapy Companies Added to the Index. 
From Business Wire News Releases
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance 
From Business Wire News Releases
Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program
Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program 
From Business Wire News Releases
Market’s Only Cancer Immunotherapy ETF Launches
Market’s Only Cancer Immunotherapy ETF Launches; Exchange Traded Concepts Partners with Loncar Investments, ISE ETF Venture, and Amplify Development on the Loncar Cancer Immunotherapy ETF (CNCR) 
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.